Inactivating TP53 and RB1 mutations play a major role in SCLC development, as suggested by the observation that lung tumors formed in TP53 and RB1 double knockout mice exhibit many features similar to those observed in humans in SCLC tumors [94]. Here, RB1 is linked to small cell lung carcinoma.